Biography

Lonnie Moulder joined our Board in 2019 and serves as Chair of our Nominating and Corporate Governance Committee and as a member of our Compensation and Commercial Committees.

Mr. Moulder brings to our Board significant operational and senior management experience in the biopharmaceutical industry as well as extensive experience as a director on public and private boards in the industry.

Mr. Moulder is Founder and Managing Member of Tellus Bio Ventures, LLC, a life sciences investment fund. In addition to serving on our Board, he has also served on other public company boards, including as Chairman of the Board of Dianthus Therapeutics, Inc. (Nasdaq), and he serves on the boards of several Tellus portfolio companies.

Mr.  Moulder is also Founder, Chief Executive Officer, and Chairman of the Board of Zenas BioPharma, a clinical-stage global biopharmaceutical company focused on the development and commercialization of immunology-based therapies. Previously, he co-founded and served as Chief Executive Officer and a member of the Board of TESARO, Inc. (Nasdaq), a fully-integrated Boston based oncology-focused biopharmaceutical company with operations in North America and Europe, until its acquisition by GlaxoSmithKline. Prior to that, he served as President, Chief Executive Officer, and Vice Chairman of the Board of Abraxis BioScience, Inc. (Nasdaq), prior to its eventual acquisition by Celgene Corporation. He also served as Vice Chairman of Eisai Corporation of North America following Eisai’s acquisition of MGI PHARMA, where he served in various roles, including as President, Chief Executive Officer, and member of the Board; President and Chief Operating Officer; and Executive Vice President.

Mr. Moulder began his career as a clinical pharmacist followed by a seventeen-year career at predecessor companies of Sanofi, beginning with Marion Laboratories.

Mr. Moulder is a Temple University Trustee, a Council Member for the University of Chicago Booth School of Business and the Polsky Center for Entrepreneurship and Innovation, and Board Member of the Fox Chase Cancer Center.

Mr. Moulder received an MBA from The University of Chicago Booth School of Business in 1997 and a B.S. in Pharmacy from Temple University.